Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
5
|
pubmed:dateCreated |
1982-9-24
|
pubmed:language |
spa
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0014-2565
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
15
|
pubmed:volume |
164
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
279-83
|
pubmed:dateRevised |
2008-11-21
|
pubmed:meshHeading |
pubmed-meshheading:7100540-Antibody Formation,
pubmed-meshheading:7100540-Celiac Disease,
pubmed-meshheading:7100540-Complement Pathway, Alternative,
pubmed-meshheading:7100540-Dysgammaglobulinemia,
pubmed-meshheading:7100540-Glutens,
pubmed-meshheading:7100540-Humans,
pubmed-meshheading:7100540-Immunity, Cellular,
pubmed-meshheading:7100540-Immunoglobulin A, Secretory
|
pubmed:year |
1982
|
pubmed:articleTitle |
[Immunopathologic aspects of celiac disease].
|
pubmed:publicationType |
Journal Article
|